Srinivasan S R, Vijayagopal P, Eberle K, Radhakrishnamurthy B, Berenson G S
Department of Medicine, Louisiana State University Medical Center, New Orleans 70112.
Biochim Biophys Acta. 1991 Jan 28;1081(2):188-96. doi: 10.1016/0005-2760(91)90025-d.
A high-affinity heparin subfraction accounting for 8% of whole heparin from bovine lung was isolated by low-density lipoprotein (LDL)-affinity chromatography. When compared to whole heparin, the high-affinity subfraction was relatively higher in molecular weight (11,000 vs. 17,000) and contained more iduronyl sulfate as hexuronic acid (76% vs. 86%), N-sulfate ester (0.75 vs. 0.96 mol/mol hexosamine), and O-sulfate ester (1.51 vs. 1.68 mol/mol hexosamine). Although both heparin preparations formed insoluble complexes with LDL quantitatively in the presence of 30 mM Ca2+, the concentrations of NaCl required for 50% reduction in maximal insoluble complex formation was markedly higher with high-affinity subfraction (0.55 M vs. 0.04 M). When compared to complex of 125I-LDL and whole heparin (H-125I-LDL), complex of 125I-LDL and high-affinity heparin subfraction (HAH-125I-LDL) produced marked increase in the degradation of lipoproteins by macrophages (7-fold vs. 1.4-fold over native LDL, after 5 h incubation) as well as cellular cholesteryl ester synthesis (16.7-fold vs. 2.2-fold over native LDL, after 18 h incubation) and content (36-fold vs. 2.7-fold over native LDL, after 48 h incubation). After a 5 h incubation, macrophages accumulated 2.3-fold more cell-associated radioactivity from HAH-125I-LDL complex than from [125I]acetyl-LDL. While unlabeled HAH-LDL complex produced a dose-dependent inhibition of the degradation of labeled complex, native unlabeled LDL did not elicit any effect even at a 20-fold excess concentration. Unlabeled particulate LDL aggregate competed for 33% of degradation of labeled complex; however, cytochalasin D, known inhibitor of phagocytosis, did not effectively inhibit the degradation of labeled complex. Unlabeled acetyl-LDL produced a partial (33%) inhibition of the degradation of labeled complex. These results indicate that (1) the interaction of high-affinity heparin subfraction with LDL leads to scavenger receptor mediated endocytosis of the lipoprotein, and stimulation of cholesteryl ester synthesis and accumulation in the macrophages; and (2) with respect to macrophage recognition and uptake, HAH-LDL complex was similar but not identical to acetyl-LDL. These observations may have implications for atherogenesis, because both mast cells and endothelial cells can synthesize heparin in the arterial wall.
通过低密度脂蛋白(LDL)亲和色谱法从牛肺中分离出一种高亲和力肝素亚组分,其占全肝素的8%。与全肝素相比,该高亲和力亚组分的分子量相对较高(11,000对17,000),并且作为己糖醛酸含有更多的艾杜糖醛酸硫酸酯(76%对86%)、N - 硫酸酯(0.75对0.96摩尔/摩尔己糖胺)和O - 硫酸酯(1.51对1.68摩尔/摩尔己糖胺)。尽管两种肝素制剂在30 mM Ca2+存在下都能与LDL定量形成不溶性复合物,但高亲和力亚组分使最大不溶性复合物形成减少50%所需的NaCl浓度明显更高(0.55 M对0.04 M)。与125I - LDL和全肝素的复合物(H - 125I - LDL)相比,125I - LDL和高亲和力肝素亚组分的复合物(HAH - 125I - LDL)使巨噬细胞对脂蛋白的降解显著增加(孵育5小时后,相对于天然LDL增加7倍对1.4倍),以及细胞胆固醇酯合成增加(孵育18小时后,相对于天然LDL增加16.7倍对2.2倍)和含量增加(孵育48小时后,相对于天然LDL增加36倍对2.7倍)。孵育5小时后,巨噬细胞从HAH - 125I - LDL复合物中积累的细胞相关放射性比从[125I]乙酰化LDL中多2.3倍。虽然未标记的HAH - LDL复合物对标记复合物的降解产生剂量依赖性抑制,但天然未标记的LDL即使在浓度高20倍时也没有产生任何影响。未标记的颗粒状LDL聚集体竞争33%的标记复合物降解;然而,已知的吞噬作用抑制剂细胞松弛素D并没有有效抑制标记复合物的降解。未标记的乙酰化LDL对标记复合物的降解产生部分(33%)抑制。这些结果表明:(1)高亲和力肝素亚组分与LDL的相互作用导致脂蛋白通过清道夫受体介导的内吞作用,并刺激巨噬细胞中胆固醇酯的合成和积累;(2)就巨噬细胞的识别和摄取而言,HAH - LDL复合物与乙酰化LDL相似但不完全相同。这些观察结果可能对动脉粥样硬化的发生有影响,因为肥大细胞和内皮细胞都可以在动脉壁中合成肝素。